Does a clinical scientist led cardio-oncology clinic improve surveillance for cardio-toxicity for patients receiving trastuzumab compared to oncology services alone?

25 May 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 4 - Cardiovascular Disease in Special Populations Cardio-Oncology HFA Premium Access Heart Failure 2019

ESC 365 is supported by

ESC 365 is supported by